A prospective, open label clinical study to evaluate the efficacy and safety of Hair serum on Hair Growth and Hair Fall in healthy adult humans.

Sami Labs Limited0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 Male and female healthy adult subjects ranging in age from 18 to 65 years both inclusive.
•2 Willingness to follow the protocol requirements as evidenced by written informed consent.
•3 Agree not to use any medication, including vitamins and minerals during or before the course of this study.
•4 Mild to moderate hair loss classified as the Norwood-Hamilton type II,III,IV and V in males and Ludwig type I and II in females.
•5 Willing to come for all follow-up visits.

•1 Any clinically significant medical history, medical finding or an on-going medical or psychiatric condition exists which in the opinion of the Investigator could jeopardize the safety of the subject, impact validity of the study results or interfere with the completion of study according to the protocol.
•2 On any medication or supplement for hair loss, including finasteride, any other 5 Î±-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to study commencement.
•3 History of hypersensitivity reactions.
•4 Participation in a clinical study during the preceding 90 days.

发起方

Sami Labs Limited